retatrutide safety study Efficacy and of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Retatrutide is getting attention —

Eat enough protein : It supports collagen production and maintains muscle tone

Persistent hunger often signals a metabolic imbalance that requires attention

April 16, 2025: Parties in Trulicity Lawsuit to Hold Hearing on Gastroparesis On May 14, 2025, the parties involved in the Trulicity multidistrict litigation will hold a hearing about the reliable diagnostic process for gastroparesis

By combining careful assessment, clear communication, and evolving evidence, clinicians can reduce aspiration risk while maintaining optimal patient outcomes

The same fundamental principles apply: gentle handling, correct diluent, proper storage

On the other hand, Semaglutide is FDA-approved for weight management and type 2 diabetes